Back to search

Vascular endothelial growth factor receptor-2-blocking antibody potentiates radiation-induced long-term control of human tumor xenografts.

Data up to Jan 2025

Published2001
Citations300
References24
Clinical Trials (1)

Total Citations Per Year

Abstract

References (24)

Angiogenesis in cancer and other diseases

2000 • 8,734 citations

Antiangiogenic scheduling of chemotherapy improves efficacy against experimental drug-resistant cancer.

2000 • 1,536 citations

Continuous low-dose therapy with vinblastine and VEGF receptor-2 antibody induces sustained tumor regression without overt toxicity

2000 • 1,159 citations

Tumor Induction of VEGF Promoter Activity in Stromal Cells

1998 • 964 citations

Blockage of the vascular endothelial growth factor stress response increases the antitumor effects of ionizing radiation.

1999 • 866 citations

Time-dependent vascular regression and permeability changes in established human tumor xenografts induced by an anti-vascular endothelial growth factor/vascular permeability factor antibody

1996 • 718 citations

Combined effects of angiostatin and ionizing radiation in antitumour therapy

1998 • 679 citations

Anti-Vascular endothelial growth factor treatment augments tumor radiation response under normoxic or hypoxic conditions.

2000 • 676 citations

Antivascular endothelial growth factor receptor (fetal liver kinase 1) monoclonal antibody inhibits tumor angiogenesis and growth of several mouse and human tumors.

1999 • 660 citations

Hypoxic fractions of solid tumors: Experimental techniques, methods of analysis, and a survey of existing data

1984 • 610 citations

Vascular Endothelial Growth Factor: Molecular and Biological Aspects

1999 • 542 citations

Vascular permeability factor/vascular endothelial growth factor:A multifunctional angiogenic cytokine

1997 • 474 citations

Endothelial cell death, angiogenesis, and microvascular function after castration in an androgen-dependent tumor: Role of vascular endothelial growth factor

1998 • 378 citations

Oxygen in Human Tumors: Correlations between Methods of Measurement and Response to Therapy: Summary of a Workshop Held November 19-20, 1992, at the National Cancer Institute, Bethesda, Maryland

1993 • 298 citations

Tumor oxygenation in hormone-dependent tumors during vascular endothelial growth factor receptor-2 blockade, hormone ablation, and chemotherapy.

2000 • 127 citations

An antiangiogenic agent (TNP-470) inhibited reoxygenation during fractionated radiotherapy of murine mammary carcinoma

1997 • 115 citations

Antiangiogenic agents can increase tumor oxygenation and response to radiation therapy

1994 • 94 citations

Potentiation of cytotoxic therapies by TNP-470 and minocycline in mice bearing EMT-6 mammary carcinoma

1995 • 92 citations

Assessment of local tumor control using censored tumor response data

1983 • 76 citations

A Cesium-137 Irradiator for Small Laboratory Animals

1973 • 73 citations

Irradiation of a primary tumor, unlike surgical removal, enhances angiogenesis suppression at a distal site: potential role of host-tumor interaction.

2000 • 66 citations

Effect of Fractionation of Radiation Dose on Skin Contraction and Skin Reaction of Swiss Mice

1972 • 30 citations

The Effect of Whole-Body Irradiation of Nude Mice on the Tumor Transplantability and Control Probability of a Human Soft Tissue Sarcoma Xenograft

1996 • 17 citations

Fraction of radiobiologically hypoxic cells in human melanoma xenografts measured by using single-cell survival, tumour growth delay and local tumour control as end points

1998 • 12 citations

Cited By (0)

No citing papers found in database

Vascular endothelial growth factor receptor-2-blocking antibody potentiates… (2001) – PubMed | Metascience Observatory Explorer